Article Details

SpringWorks Therapeutics' (SWTX) Buy Rating Reaffirmed at The Goldman Sachs Group

Retrieved on: 2021-03-29 12:45:00

Tags for this article:

Click the tags to see associated articles and topics

SpringWorks Therapeutics' (SWTX) Buy Rating Reaffirmed at The Goldman Sachs Group. View article details on hiswai:

Excerpt

SpringWorks Therapeutics (NASDAQ:SWTX)'s stock had its "buy" rating reiterated by The Goldman Sachs Group in a research note issued to ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up